Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors

Giovanna Calabrese1, Giovanna De Luca1, Giuseppe Nocito1

  • 1Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali-Università degli Studi di Messina, Viale Ferdinando Stagno d'Alcontres, 31, 98168 Messina, Italy.

Insights

Carbon dots show promise for treating brain tumors by overcoming the blood-brain barrier. This review explores their diagnostic and therapeutic potential in brain cancer treatment.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Brain tumors are aggressive, leading to significant mortality globally.
  • The blood-brain barrier (BBB) severely limits drug delivery for brain neoplasms.
  • Carbon dots offer potential as drug delivery systems due to their properties.

Purpose of the Study:

  • To review advances in using carbon dots for brain tumor diagnosis and therapy.
  • To explore strategies for enhancing carbon dot penetration of the BBB.
  • To identify challenges in applying carbon dots to brain cancer treatment.

Main Methods:

  • Literature review of recent studies on carbon dots in brain cancer therapy.
  • Analysis of carbon dot properties relevant to drug delivery and theranostics.
  • Examination of methods to overcome the blood-brain barrier for carbon dots.

Main Results:

  • Carbon dots exhibit photoluminescence, solubility, stability, and biocompatibility.
  • Carbon dots are being developed for both diagnostic imaging and therapeutic delivery.
  • Strategies are being investigated to enable carbon dots to cross the BBB.

Conclusions:

  • Carbon dots represent a promising platform for brain cancer theranostics.
  • Overcoming the BBB remains a key challenge for effective carbon dot application.
  • Further research is needed to optimize carbon dots for brain tumor treatment.